Cue Biopharma Inc (CUE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Sales | 475 | 704 | 1,075 | 900 | 1,049 |
| Gross Profit | 475 | 704 | 1,075 | 900 | 1,049 |
| Operating Expenses | 11,450 | 10,835 | 12,017 | 13,895 | 10,067 |
| Operating Income | -10,975 | -10,131 | -10,942 | -12,995 | -9,017 |
| Other Income | 78 | 100 | 109 | 177 | 97 |
| Pre-tax Income | -10,897 | -10,031 | -10,833 | -12,818 | -8,921 |
| Income Tax | N/A | N/A | N/A | N/A | -1 |
| Net Income Continuous | -11,103 | -10,031 | -10,833 | -12,818 | -8,920 |
| Net Income | $-11,103 | $-10,031 | $-10,833 | $-12,818 | $-8,920 |
| EPS Basic Total Ops | -0.36 | -0.34 | -0.38 | -0.48 | -0.35 |
| EPS Basic Continuous Ops | -0.36 | -0.34 | -0.38 | -0.48 | -0.35 |
| EPS Diluted Total Ops | -0.36 | -0.34 | -0.38 | -0.48 | -0.35 |
| EPS Diluted Continuous Ops | -0.36 | -0.34 | -0.38 | -0.48 | -0.35 |
| EBITDA(a) | $-10,714 | $-9,840 | $-10,615 | $-12,732 | $-8,884 |